623 related articles for article (PubMed ID: 9434808)
21. [Comparison of anti-hepatitis C virus (HCV) IgM and HCV-RNA detection in serum samples of patients with HCV infection].
Lei Z; Lu H; Han F; Shi H; Lu J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):121-3. PubMed ID: 15619814
[TBL] [Abstract][Full Text] [Related]
22. The microhemagglutination assay for Treponema pallidum antibodies (MHA-TP), a new treponemal test for syphilis: where does it fit?
Rudolph AH
J Am Vener Dis Assoc; 1976 Sep; 3(1):3-8. PubMed ID: 795798
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic tests for hepatitis C.
Gretch DR
Hepatology; 1997 Sep; 26(3 Suppl 1):43S-47S. PubMed ID: 9305663
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of hepatitis C viral RNA status and its correlation to antibodies to structural HCV antigens in anti-HCV reactive patients with normal liver tests.
Fong TL; Lee SR; Briggs WK; Valinluck B; Govindarajan S; Hoffman A; Jaczko B; Redeker AG
J Med Virol; 1996 Jul; 49(3):253-8. PubMed ID: 8818974
[TBL] [Abstract][Full Text] [Related]
25. Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.
Yang JF; Lin YY; Hsieh MH; Tsai CH; Liu SF; Yu ML; Dai CY; Huang JF; Lin WY; Lin ZY; Chen SC; Chuang WL
Kaohsiung J Med Sci; 2011 Jul; 27(7):258-63. PubMed ID: 21757142
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of the anti-TP antibody latex agglutination immunoassay in routine testing and a clinical viewpoint].
Fujimori C; Yukimasa N; Miura K; Mochizuki S; Yasuhara T; Takagi Y; Gomi K
Rinsho Byori; 2009 Mar; 57(3):206-12. PubMed ID: 19363990
[TBL] [Abstract][Full Text] [Related]
27. [Quantitative antibody analysis: use for the diagnosis of hepatitis C virus chronic infection].
Payan C; Raimbert A; Fouchard-Hubert I; Kouyoumdjian S; Lunel-Fabiani F
Ann Biol Clin (Paris); 2003; 61(3):311-7. PubMed ID: 12805008
[TBL] [Abstract][Full Text] [Related]
28. Clinical utility and characteristics of nine anti-HCV antibody screening reagents used in Japan.
Kita M; Deguchi M; Kagita M; Yoshioka N; Kobayashi E; Watanabe M; Asari S; Yamanaka K; Iwatani Y
Clin Lab; 2009; 55(1-2):9-22. PubMed ID: 19350845
[TBL] [Abstract][Full Text] [Related]
29. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
[TBL] [Abstract][Full Text] [Related]
30. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.
Espinosa M; Martin-Malo A; Alvarez de Lara MA; Soriano S; Aljama P
Clin Nephrol; 2000 Aug; 54(2):151-6. PubMed ID: 10968693
[TBL] [Abstract][Full Text] [Related]
31. [Prevalence of antibodies against hepatitis C virus in rheumatoid arthritis. Study using second-generation tests].
Marson P; Vicarioto M; Cavasin F; Volante D; De Silvestro G
Recenti Prog Med; 1991 Dec; 82(12):679-81. PubMed ID: 1667711
[TBL] [Abstract][Full Text] [Related]
32. Third-generation assays for hepatitis C antibodies: a four-year study of pattern changes in patients with chronic and past infection.
Perniola R; De Rinaldis C; Leo G
Panminerva Med; 1999 Dec; 41(4):291-4. PubMed ID: 10705708
[TBL] [Abstract][Full Text] [Related]
33. [The status and significance of mother-to-infant transmission of hepatitis C virus determined by nested polymerase chain reaction].
Hao F; Li M; Thaler MM; Chen G
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):127-9. PubMed ID: 15619816
[TBL] [Abstract][Full Text] [Related]
34. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P
Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921
[TBL] [Abstract][Full Text] [Related]
35. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
[TBL] [Abstract][Full Text] [Related]
36. The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.
Hussein MM; Mooij JM; Hegazy MS; Bamaga MS
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):107-13. PubMed ID: 17237902
[TBL] [Abstract][Full Text] [Related]
37. Qualitative and quantitative aspects of the serological diagnosis of early syphilis.
McMillan A; Young H
Int J STD AIDS; 2008 Sep; 19(9):620-4. PubMed ID: 18725554
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C infection in dialysis patients in Israel.
Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
[TBL] [Abstract][Full Text] [Related]
39. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course.
Sagnelli E; Coppola N; Messina V; Di Caprio D; Marrocco C; Marotta A; Onofrio M; Scolastico C; Filippini P
Hepatology; 2002 Nov; 36(5):1285-91. PubMed ID: 12395342
[TBL] [Abstract][Full Text] [Related]
40. [Use of combined detection of hepatitis C virus core antigen and antibodies to reduce the serological window-phase].
Hmaïed F; Ben Mamou M; Arrouji Z; Slim A; Ben Redjeb S
Pathol Biol (Paris); 2007 Mar; 55(2):121-6. PubMed ID: 16631320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
